MDGL
NASDAQ · Biotechnology
Madrigal Pharmaceuticals Inc
$445.04
-2.68 (-0.60%)
Performance
1D
—
1W
—
1M
—
3M
-25.69%
6M
+4.91%
1Y
+29.64%
YTD
-25.06%
Open$445.00
Previous Close$447.72
Day High$449.14
Day Low$437.05
52W High$615.00
52W Low$265.00
Volume—
Avg Volume358.8K
Market Cap10.08B
P/E Ratio—
EPS$-12.85
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$526.21
Below
SMA 200
$421.32
Above
RSI (14)
32.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
23 analysts
Price Target
-73.1% upside
Current
$445.04
$445.04
Target
$119.83
$119.83
$78.20
$119.83 avg
$127.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 994.74M | 3.52B | 3.21B |
| Net Income | -299,214,532 | -1,086,916,353 | -1,008,552,409 |
| Profit Margin | -30.1% | -30.9% | -31.4% |
| EBITDA | -313,278,670 | -994,214,061 | -913,486,769 |
| Free Cash Flow | — | -874,407,524 | -958,278,915 |
| Rev Growth | — | +9.6% | -7.9% |
| Debt/Equity | 0.56 | 0.46 | 0.46 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |